TIBCO Spotfire to Present at the Sixteenth Annual Biopharmaceutical Applied Statistics Symposium (BASS XVI)

Tue. November 03, 2009; Posted: 09:00 AM

Look up the PowerRating of TIBX and see how it has performed over the past week as well as the current proprietary PowerRating.

SOMERVILLE, MA, Nov 03, 2009 (MARKETWIRE via COMTEX) -- TIBX | Quote | Chart | News | PowerRating -- e> What: TIBCO Spotfire Director of Life Sciences, Dr. Michael O'Connell, will present a session titled 'Graphics for Exploratory Analysis and Reporting in Clinical Trials' at the Biopharmaceutical Applied Statistics Symposium (BASS XVI) next week. Session Overview: Clinical trials are complex. With so many safety and efficacy endpoints, and information that must be summarized and disseminated to a variety of stakeholders, graphics can help promote better science and more effective communication. Dr. O'Connell will discuss how clinical graphics and interactive data review methods can be used to identify safety signals, assess protocol adherence and help with the analysis and reporting of safety and efficacy data. Session attendees will learn: -- The difference between exploratory and reporting graphics and how this impacts the analysis of clinical trials. -- The various graph types available from TIBCO Spotfire for use in exploratory analysis and the reporting of safety and efficacy data. -- How end users can create their own graphics and interactively review templates and share them for use on clinical trial data across a variety of functional areas. Where: The conference is being held on November 9-13, 2009 at the Mulberry Inn in Savannah, GA. When: Dr. O'Connell will present on Tuesday, November 10, 2009 at 11:10 a.m. local time. Information: For more information about the BASS XVI conference, visit: http://bass.georgiasouthern.edu.

Successful applications of the TIBCO Spotfire(R) enterprise analytics platform in the Life Sciences market are currently being discussed by leading pharmaceutical customers at various industry conferences, including most recently at the PhUSE 2009 conference in Basel, October 19-21, 2009, and the DIA 3rd Annual Clinical Forum in Nice, France, October 19-21, 2009. To learn more about where TIBCO Spotfire executives and customers will be presenting in the coming year, please visit TIBCO Spotfire's events page at http://spotfire.tibco.com/News/Default.aspx.

About TIBCO

TIBCO Software Inc. (NASDAQ: TIBX | Quote | Chart | News | PowerRating) is a leading provider of enterprise analytics software for next generation business intelligence. TIBCO Spotfire products offer a visual and interactive experience that helps professionals quickly discover new and actionable insights in information. Distinguished by its speed to insight and adaptability to specific business challenges, Spotfire rapidly reveals unseen threats and new opportunities, creating significant economic value. Spotfire customers include industry leaders among the Global 2000 that have deployed Spotfire analytics to gain an information advantage over their competitors. For more information, visit http://spotfire.tibco.com.

TIBCO, TIBCO Software, TIBCO Spotfire are trademarks or registered trademarks of TIBCO Software Inc. or its subsidiaries in the United States and/or other countries. All other product and company names and marks mentioned in this document are the property of their respective owners and are mentioned for identification purposes only.

Media Inquiries
Amy Groden-Morrison
TIBCO Software Inc.
617-702-1710
amorriso@tibco.com
http://spotfire.tibco.com

Toni Iafrate
Davies Murphy Group
781-418-2406
tiafrate@daviesmurphy.com
http://daviesmurphy.com

SOURCE: TIBCO Software Inc.

mailto:amorriso@tibco.com
http://spotfire.tibco.com
mailto:tiafrate@daviesmurphy.com
http://daviesmurphy.com

For full details on Tibco Software Inc (TIBX) click here. Tibco Software Inc (TIBX) has Short Term PowerRatings of 5. Details on Tibco Software Inc (TIBX) Short Term PowerRatings is available at This Link.

More News: Market Updates | Stock Alerts | All Trading News | Stock Index

Archives

Feedback

Email Article Link

Close X

RELATED SITES

Please call 1-213-955-5858 ext. 1

Tax Relief Bank Levy Wage Garnishment

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.